Spinal Muscular Atrophy Type 1 -Werdnig-Hoffmann Disease

17:08 Posted by Ahmed Khalil

What is SMA?
Spinal Muscular Atrophy (SMA) refers to a group of diseases which affect the motor neurons of the spinal cord and brain stem. These critically important cells are responsible for supplying electrical and chemical messages to muscle cells. Without the proper input from the motor neurons, muscle cells cannot function properly. The muscle cells will, therefore, become much smaller (atrophy) and will produce symptoms of muscle weakness. There are dozens of diseases which affect the motor neuron.
 
What cause SMA?
Infantile SMA is caused by an altered gene that does not function they way it should. SMA is passed on by what is known as autosomal recessive inheritance. In our bodies, we all have 46 chromosomes, which form 23 pairs. 22 of these pairs are numbered (1 – 22), which are known as autosomes. The last pair of chromosomes, known as the sex chromosomes, determine the gender that individual. A female has two X chromosomes, whilst males have one X and one Y chromosome to make up the 23rd pair. In SMA, the altered gene is located on chromosome 5, an autosomal chromosome. As we all have two copies of chromosome 5 (one from our mother, and their other from our father), if we have one altered gene, the second copy acts as a back up and therefore we are not affected. For an individual to be affected with SMA, they need to have inherited 2 altered genes from their parents. This means, both parents must carry one copy of the altered gene which they both pass onto their child. If a couple already has a child with the disorder, each of their subsequent children has a 25 per cent (or 1 in 4) chance of inheriting the disorder too. Genetic counselling is available for these couples.
Nerve cells called motor neurones link muscle fibres to the nervous system. The instruction to contract a muscle is sent from the brain along the spinal cord and through the motor neurones to the muscle fibres. Spinal muscular atrophies are inherited disorders characterised by the deterioration of these motor neurones. As a result, the muscles don’t receive messages from the nervous system. This lack of movement causes the muscles to weaken and wither away. Motor neurones in the brain stem may also be affected. The brain stem sits on top of the spinal cord and oversees the functioning of the face, jaw, tongue, eyes and throat. Spinal muscular atrophies are categorised by the age of onset. The symptoms of infantile spinal muscular atrophy (infantile SMA) appear before the age of two years, and are sometimes present at birth. A child with infantile SMA rarely survives beyond the age of three years.
 
Different categories according to age
Spinal muscular atrophies (SMA) are categorised by the age of onset. The categories include:
  • Infantile SMA - also known as Type 1 SMA or Werdnig-Hoffman disease
  • Intermediate SMA - Type 2 SMA
  • Juvenile SMA - also known as Type 3 SMA or Kugelberg-Welander disease
  • Adult onset SMA - Type 4 SMA.
 
Symptoms
Infantile SMA is the most severe form. The symptoms include:
  • Muscle weakness
  • Poor muscle tone
  • Weak cry
  • Limpness or a tendency to flop
  • The legs tend to be weaker than the arms
  • Feeding difficulties
  • Increased susceptibility to respiratory tract infections
  • Developmental milestones, such as lifting the head or sitting up, can’t be reached.
 
The onset of symptoms
Children with Infantile SMA are diagnosed usually before 6 months of age, more often before 3 months of age.  Symptoms may even start in the womb.  Many mothers later recall the baby not moving as much the last month or so of pregnancy.  They are not able to hold up their heads, roll over, crawl, sit up without support, or walk.  All of their muscles are extremely weak, with the weakest muscles being the legs, upper arms, and neck.  Their chest may appear concave, or very skinny at the top, with a big belly.  Bell-shaped.  SMA affects all muscle systems as well including sucking, swallowing, digesting food, and excretion.
Generally speaking, the child’s survival depends on the age of onset of the condition. The earlier the symptoms appear, the shorter the expected life span. In some cases, the baby stops moving in the later stages of its mother’s pregnancy. Sometimes, the symptoms don’t appear for days, weeks or even months after birth. The onset can be sudden and dramatic, or very gradual. However, once the symptoms appear, the child quickly deteriorates.
 
Testing for SMA
DNA testing is available, however, that is generally the last part of the testing process. This is because there is so much information that is present on our DNA, it is too hard to test. By performing preliminary tests, the information that is gained from the results narrows down the section of DNA that needs to be investigated. Such preliminary tests include:
  • Creatine Kinase (CK) Levels
  • Electromyography (EMG)
  • Motor and sensory nerve conduction velocities (NCV)
  • Muscle biopsy
A simple blood test for an enzyme called creatine kinase (CK) is usually the first step in the diagnosis process. This enzyme leaks out of muscles that are deteriorating. It’s a nonspecific test, since CK levels are elevated in many neuromuscular diseases, but it’s often useful anyway. High blood CK levels aren’t harmful; they’re just an indicator of muscle damage.
 
An EMG and NCV are two tests that analyse how the muscles are nerves are functioning. EMG is an electrical recording of muscle activity that aids in the diagnosis of neuromuscular disease, while the NCV measures the ability of the nerve to conduct electrical signals. Both tests are usually performed at the same time using the same equipment.
 
A muscle biopsy removes a tiny section of muscle that is analysed at a miscroscopic level for signs of SMA. In children, a punch muscle biopsy may be used.
 
Pneumonia is a common complication
A child with infantile SMA is prone to respiratory infections. Pneumonia is a type of lung infection where the smallest airways, called the alveoli, are blocked with mucus and secretions. In healthy people, pneumonia can be simply treated with antibiotics. However, a child with infantile SMA is already in a weakened and vulnerable state. Pneumonia is the cause of death in the majority of cases.
 
Anesthesia Concerns
A child with SMA who must undergo surgery (for example, to correct scoliosis) needs to take special precautions. The surgical team, particularly the anesthesiologist, must thoroughly understand SMA.
Sometimes, especially in the early stages of SMA, the muscle cells that aren’t receiving nerve signals develop certain abnormalities as they try to "reach out" to nerves. These abnormalities can lead to dangerous reactions to muscle-relaxing drugs often used during surgery. Doctors can get around this problem if they’re aware of it, by using different drugs.
 
Treatment of SMA
Unfortunately, Infantile SMA is a fatal disorder and there is no cure. Treatment can only ease any associated complications. For instance, since a child with infantile SMA is prone to respiratory infections and pneumonia, treatment focuses on trying to maintain the child’s lung function and health. Usually, a team of professionals - paediatricians, physiotherapists, neurologists, and respiratory physicians and therapists - work together to help improve the child’s quality of life. Although most children affected with SMA die before 3 years of age, however, a small number of children with Type I SMA may survive into their teens or early adulthood
 
Things to remember
  • Infantile spinal muscular atrophy is an inherited condition.
  • The nerve cells that service the muscles don’t work properly, causing muscle weakness and withering.
  • A child with infantile spinal muscular atrophy rarely lives beyond three years of age.
  • There is no cure.
  • Digg
  • del.icio.us
  • StumbleUpon
  • Yahoo! Buzz
  • Technorati
  • Facebook
  • TwitThis
  • MySpace
  • LinkedIn
  • Live
  • Google
  • Reddit
  • Sphinn
  • Propeller
  • Slashdot
  • Netvibes

0 comments:

Post a Comment